Hana Algül
Impact in
- Oncology top 0.5%
- Pancreatic and Hepatic Oncology Research
- PARP inhibition in cancer therapy
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Cancer Research top 1%
- Cancer Genomics and Diagnostics
Papers in
- Co-authors
- Marina Lesina (23 shared papers)Roland M. Schmid (47 shared papers)Matthias Treiber (7 shared papers)Thomas M. Gress (2 shared papers)Sonja M. Wörmann (10 shared papers)David A. Tuveson (1 shared paper)Albrecht Neeße (1 shared paper)Michele Reni (17 shared papers)
- Journals
- Annals of Oncology (15 papers)Journal of Clinical Oncology (11 papers)Gastroenterology (7 papers)PLoS ONE (6 papers)Pancreatology (6 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Hana Algül
125 papers receiving 6.6k citations
Hana Algül's Hit Papers
Peers
Comparison fields: 5 of 128
- Oncology 3.5k
- Cancer Research 1.2k
- Immunology 1.2k
- Surgery 1.5k
- Pulmonary and Respiratory Medicine 770
Countries citing papers authored by Hana Algül
This map shows the geographic impact of Hana Algül's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hana Algül with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hana Algül more than expected).
Fields of papers citing papers by Hana Algül
This network shows the impact of papers produced by Hana Algül. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hana Algül. The network helps show where Hana Algül may publish in the future.
Co-authors
The 25 scholars most cited alongside Hana Algül, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 134 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancer Hit paper breakdown → | 2019 | 1530 |
| 2 | Stat3/Socs3 Activation by IL-6 Transsignaling Promotes Progression of Pancreatic Intraepithelial Neoplasia and Development of Pancreatic Cancer Hit paper breakdown → | 2011 | 682 |
| 3 | Stromal biology and therapy in pancreatic cancer: a changing paradigm Hit paper breakdown → | 2015 | 427 |
| 4 | 2017 | 267 | |
| 5 | 2013 | 217 | |
| 6 | 2013 | 150 | |
| 7 | 2014 | 146 | |
| 8 | 2007 | 145 | |
| 9 | 2018 | 137 | |
| 10 | Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer Hit paper breakdown → | 2022 | 128 |
| 11 | 2016 | 124 | |
| 12 | 2014 | 115 | |
| 13 | 2012 | 98 | |
| 14 | 2016 | 98 | |
| 15 | 2002 | 86 | |
| 16 | 2014 | 83 | |
| 17 | 2007 | 83 | |
| 18 | 2007 | 78 | |
| 19 | 2016 | 73 | |
| 20 | 2013 | 71 |
About Hana Algül
Hana Algül is a scholar working on Oncology, Surgery, Cancer Research, Pulmonary and Respiratory Medicine and Immunology, having authored 134 papers that have together received 6.7k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (45 papers), Pancreatitis Pathology and Treatment (32 papers), Cancer Genomics and Diagnostics (15 papers), PARP inhibition in cancer therapy (13 papers), Gallbladder and Bile Duct Disorders (13 papers), NF-κB Signaling Pathways (9 papers), Economic and Financial Impacts of Cancer (7 papers) and Phagocytosis and Immune Regulation (7 papers). The work is most often cited by research in Oncology (3.5k citations), Cancer Research (1.2k citations), Immunology (1.2k citations), Surgery (1.5k citations) and Pulmonary and Respiratory Medicine (770 citations). Hana Algül has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Marina Lesina, Roland M. Schmid, Matthias Treiber, Thomas M. Gress, Sonja M. Wörmann, David A. Tuveson, Albrecht Neeße, Michele Reni, Anke Reinacher‐Schick and Daniel Hochhauser. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Gastroenterology, PLoS ONE and Pancreatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.